Amylyx Pharmaceuticals, Inc.
← Back to AMLX Overview

Amylyx Pharmaceuticals, Inc. (AMLX)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-8.65

Financial Fundamentals

AMLXQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-12-31-24.16
2021-03-31-14.29
2021-06-30-9.47
2021-09-30-10.78
2021-12-31-8.80
2022-03-31-3.45
2022-06-30-5.18
2022-09-30-7.66
2022-12-31-14.15
2023-03-31311.11
2023-06-3016.42
2023-09-3014.77
2023-12-3152.44
2024-03-31-0.39
2024-06-30-0.44
2024-09-30-0.76
2024-12-31-1.73
2025-03-31-2.11
2025-06-30-3.45
2025-09-30-9.22
2025-12-31-8.65

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.